Sinovac Biotech Co., Ltd Sinovac Biotech develops inactivated and live attenuated vaccines across influenza, hepatitis, varicella, HFMD, poliomyelitis, rabies, tetanus, and pneumococcal disease, with three vaccines prequalified by the WHO.
Follow Sinovac Biotech Co., Ltd. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
3 Stories in coverage 1 Program 145 recruiting Registered trials 6-K Aug 17 Latest SEC filing, period to Aug 17 Sep 22 Latest story
Timeline 3 Pipeline 1 Trials 14
Phase 3 primary completions, next 6 months
All trials by completion date Details
Headquarters Beijing Incorporated Antigua and Barbuda Industry Pharmaceutical Preparations Formerly NET FORCE SYSTEMS INC (to 2004) Also known as NET FORCE SYSTEMS INC, SINOVAC BIOTECH LTD, Sinovac Life Sciences Co., Ltd., SVA How the company describes itself Sinovac Biotech develops inactivated and live attenuated vaccines across influenza, hepatitis, varicella, HFMD, poliomyelitis, rabies, tetanus, and pneumococcal disease, with three vaccines prequalified by the WHO. Based in China. source